EA200602073A1 - Лечение или предупреждение респираторных вирусных инфекций с помощью иммуномодуляторов - Google Patents

Лечение или предупреждение респираторных вирусных инфекций с помощью иммуномодуляторов

Info

Publication number
EA200602073A1
EA200602073A1 EA200602073A EA200602073A EA200602073A1 EA 200602073 A1 EA200602073 A1 EA 200602073A1 EA 200602073 A EA200602073 A EA 200602073A EA 200602073 A EA200602073 A EA 200602073A EA 200602073 A1 EA200602073 A1 EA 200602073A1
Authority
EA
Eurasian Patent Office
Prior art keywords
immunomodulators
prevention
treatment
viral infections
respiratory viral
Prior art date
Application number
EA200602073A
Other languages
English (en)
Other versions
EA011954B1 (ru
Inventor
Синтия У. Татхилл
Алфред Р. Рудолф
Александер А. Колобов
Андрей С. Симбирцев
Александр В. Петров
Original Assignee
Сциклон Фармасьютикалс, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сциклон Фармасьютикалс, Инк. filed Critical Сциклон Фармасьютикалс, Инк.
Publication of EA200602073A1 publication Critical patent/EA200602073A1/ru
Publication of EA011954B1 publication Critical patent/EA011954B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/30—Copper compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

В заявке описано соединение-модулятор, которое вводят пациенту, имеющему риск возникновения респираторной вирусной инфекции.
EA200602073A 2004-05-14 2005-05-12 Лечение или предупреждение респираторных вирусных инфекций с помощью иммуномодуляторов EA011954B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57094104P 2004-05-14 2004-05-14
PCT/US2005/016595 WO2005112639A2 (en) 2004-05-14 2005-05-12 Treatment or prevention of respiratory viral infections with immunomodulator compounds

Publications (2)

Publication Number Publication Date
EA200602073A1 true EA200602073A1 (ru) 2007-06-29
EA011954B1 EA011954B1 (ru) 2009-06-30

Family

ID=35428773

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200602073A EA011954B1 (ru) 2004-05-14 2005-05-12 Лечение или предупреждение респираторных вирусных инфекций с помощью иммуномодуляторов

Country Status (17)

Country Link
US (1) US20070087974A1 (ru)
EP (1) EP1748783A4 (ru)
JP (1) JP2007537280A (ru)
KR (1) KR20070012522A (ru)
CN (1) CN1964731A (ru)
AU (1) AU2005244826B2 (ru)
BR (1) BRPI0511107A (ru)
CA (1) CA2566062A1 (ru)
EA (1) EA011954B1 (ru)
IL (1) IL179046A0 (ru)
MX (1) MXPA06013050A (ru)
NO (1) NO20065518L (ru)
NZ (1) NZ551457A (ru)
SG (1) SG169362A1 (ru)
UA (1) UA92586C2 (ru)
WO (1) WO2005112639A2 (ru)
ZA (1) ZA200610454B (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006047702A2 (en) 2004-10-27 2006-05-04 Sciclone Pharmaceuticals, Inc. Treatment or prevention of hemorrhagic viral infections with immunomodulator compounds
WO2006116053A1 (en) * 2005-04-22 2006-11-02 Sciclone Pharmaceuticals, Inc. Immunomodulator compounds as vaccine enhancers
UA96980C2 (ru) 2007-02-13 2011-12-26 Сайклон Фармасютикалс, Инк. Способ уменьшения степени ухудшения состояния, поражения или повреждения слизистой оболочки
RU2007118237A (ru) * 2007-05-17 2008-11-27 ООО "Научно-производственна фирма Верта" (RU) Способ лечения аллергических заболеваний
RU2438694C1 (ru) * 2010-12-23 2012-01-10 Общество с ограниченной ответственностью "ЦитоНИР" (ООО "ЦитоНИР") Фармацевтическая композиция для лечения вирусных заболеваний

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) * 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
US4917888A (en) * 1985-06-26 1990-04-17 Cetus Corporation Solubilization of immunotoxins for pharmaceutical compositions using polymer conjugation
US4766106A (en) * 1985-06-26 1988-08-23 Cetus Corporation Solubilization of proteins for pharmaceutical compositions using polymer conjugation
US5122614A (en) * 1989-04-19 1992-06-16 Enzon, Inc. Active carbonates of polyalkylene oxides for modification of polypeptides
US5888980A (en) * 1994-06-30 1999-03-30 Bio-Logic Research And Development Corporation Compositions for enhancing immune function
US5908621A (en) * 1995-11-02 1999-06-01 Schering Corporation Polyethylene glycol modified interferon therapy
US5744452A (en) * 1995-11-28 1998-04-28 Edward T. Wei γ-L-glutamyl containing immunomodulator compounds and methods therewith
US5916878A (en) * 1995-11-28 1999-06-29 Edward T. Wei γ-glutamyl and β-aspartyl containing immunomodulator compounds and methods therewith
RU2229892C2 (ru) * 2001-06-08 2004-06-10 Государственное учреждение "Санкт-Петербургский научно-исследовательский институт фтизиопульмонологии" Способ лечения туберкулеза легких

Also Published As

Publication number Publication date
IL179046A0 (en) 2007-03-08
WO2005112639A3 (en) 2006-11-09
NO20065518L (no) 2006-11-29
US20070087974A1 (en) 2007-04-19
MXPA06013050A (es) 2007-03-28
AU2005244826A1 (en) 2005-12-01
EP1748783A2 (en) 2007-02-07
EA011954B1 (ru) 2009-06-30
UA92586C2 (ru) 2010-11-25
NZ551457A (en) 2009-12-24
CA2566062A1 (en) 2005-12-01
SG169362A1 (en) 2011-03-30
ZA200610454B (en) 2009-07-29
WO2005112639A2 (en) 2005-12-01
CN1964731A (zh) 2007-05-16
AU2005244826B2 (en) 2010-07-29
BRPI0511107A (pt) 2007-11-27
EP1748783A4 (en) 2009-08-05
KR20070012522A (ko) 2007-01-25
JP2007537280A (ja) 2007-12-20

Similar Documents

Publication Publication Date Title
TW200733953A (en) Materials and methods for treating viral infections
ZA202002139B (en) Combination pharmaceutical agents as rsv inhibitors
EA201000556A1 (ru) Спиропирролидины и их применение для борьбы с инфицированием посредством hcv (вирус гепатита с) и вич (вирус иммунодефицита человека)
GEP20146134B (en) Inhibitors of hepatitis c virus replication
DE50311898D1 (de) Fredericamycin-derivate als arzneimittel zur tumorbehandlung
GB0612423D0 (en) Therapeutic agents
EA200900156A1 (ru) Пиридазиновое соединение (варианты), способ его получения (варианты), способ лечения или профилактики инфекционного вирусного гепатита с с его помощью, композиция и лекарственное средство на его основе
EA200901080A1 (ru) Новые нуклеозидные аналоги для лечения вирусных инфекций
WO2005084315A3 (en) Pyranoindole derivatives and the use thereof for the treatment of hepatitis c virus infection or disease
EA201170605A1 (ru) Циклоундекадепсипептидные соединения и применение указанных соединений в качестве лекарственного средства
EA200602073A1 (ru) Лечение или предупреждение респираторных вирусных инфекций с помощью иммуномодуляторов
EA200702336A1 (ru) ПРИМЕНЕНИЕ 24-норУДХК
NO20055512L (no) Terapi eller prevensjon av respiratoriske, virale infeksjoner med alfa-tyimosinpeptider
DK1670489T3 (da) Brug af xenon med hypotermi til behandling af neonatal asfyksi
WO2010138419A3 (en) Materials and methods for treating viral infections
MX2022013722A (es) Cisteamina para el tratamiento de infección por sars-cov-2.
WO2007076091A3 (en) Treatment of viral infections using a tissue factor inhibitor
WO2009023356A3 (en) Materials and methods for treating influenza infections
SE0200198D0 (sv) New use
IL182710A0 (en) Treatment or prevention of hemorrhagic viral infections with immunomodulator compounds
WO2007123868A3 (en) Organic thiophosphate antiretroviral agents
DK1924255T3 (da) Anvendelse af N-(dibenz(B,F)oxepin-10-ylmethyl)-N-methyl-N-prop-2-ynylamin (OMIGAPIL) til profylakse og/eller behandling af muskeldystrofi
EA201000738A1 (ru) Медицинское применение 3-(2,2,2-триметилгидразиниум)пропионат гидрофумарата и дигидрофосфата
DK1363617T3 (da) Cyanoacrylatsammensætninger til terapeutisk behandling af sår, som kræver revision
DK1490049T3 (da) Citalopram til behandling af forhöjet blodtryk

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU